This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Jump to section
Related Articles
Cited By...
- Radiopeptide Imaging and Therapy in Europe
- Selection of Radiolabeled Gastrin Analogs for Peptide Receptor-Targeted Radionuclide Therapy
- Receptor-Mediated Tumor Targeting with Radiolabeled Peptides: There Is More to It than Somatostatin Analogs
- Added value of gastrin receptor scintigraphy in comparison to somatostatin receptor scintigraphy in patients with carcinoids and other neuroendocrine tumours
- [Lys40(Ahx-DTPA-111In)NH2]Exendin-4, a Very Promising Ligand for Glucagon-like Peptide-1 (GLP-1) Receptor Targeting
- CCK-2/Gastrin Receptor-Targeted Tumor Imaging with 99mTc-Labeled Minigastrin Analogs
- In Vitro and In Vivo Evaluation of 111In-DTPAGlu-G-CCK8 for Cholecystokinin-B Receptor Imaging
- Preclinical Evaluation of a New, Stabilized Neurotensin(8-13) Pseudopeptide Radiolabeled with 99mTc
- Y1-Mediated Effect of Neuropeptide Y in Cancer: Breast Carcinomas as Targets